SCHEMBL17681383

SCHEMBL17681383

O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 11/20 1.00
▸ KMT2A Q03164 11/20 1.00
▸ ALDH1A1 P00352 9/20 1.00
▸ MAPT P10636 7/20 1.00
▸ HTT P42858 7/20 1.00
▸ CNR1 P21554 6/20 1.00
▸ RECQL P46063 4/20 1.00
▸ GPR55 Q9Y2T6 4/20 1.00
▸ TDP1 Q9NUW8 3/20 1.00
▸ POLB P06746 5/20 0.91
▸ L3MBTL1 Q9Y468 2/20 0.91
▸ BLM P54132 1/20 0.91
▸ MCL1 Q07820 1/20 0.91
▸ HPGD P15428 2/20 0.79
▸ LMNA P02545 4/20 0.71
▸ KDM4E B2RXH2 6/20 0.68
▸ CYP3A4 P08684 2/20 0.66
▸ PTGS1 P23219 1/20 0.66
▸ CYP1A2 P05177 1/20 0.65
▸ CYP2D6 P10635 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17681378 0.95 MAPT (1.00) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL17681379 0.92 MEN1 (0.84) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113525 0.88 KMT2A (0.78) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113174 0.88 ALDH1A1 (0.78) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113159 0.86 ALDH1A1 (0.76) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113203 0.84 KMT2A (0.73) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15116289 0.81 CYP3A4 (0.75) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL17681381 0.81 MAPT (0.79) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113243 0.81 MEN1 (0.67) MEN1KMT2AALDH1A1MAPTHTT
SCHEMBL15113512 0.80 KMT2A (0.67) MEN1KMT2AALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2019-07-16 — — US claimed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US claimed
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2019-07-16 — — US disclosed
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2019-07-16 — — US disclosed
US-10076529-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2018-09-18 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed
US-9315464-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase NANT HOLDINGS IP, LLC (US) 2016-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10076529-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase RNGTT, MED23, MED25 MEN1 4837/4885KMT2A 534/4885ALDH1A1 3512/4885
US-10350225-B1 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase RNGTT, MED23, MED25 MEN1 4837/4885KMT2A 534/4885ALDH1A1 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback